Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | AKT1 | P31749 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | TGM2 | P21980 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fluoride SCHEMBL27718731 | 0.97 | TSHR (0.39) | TSHRALDH1A1AKT1ALOX15 | |
| SCHEMBL1712669 | 0.77 | TSHR (0.41) | TSHRALDH1A1AKT1ALOX15TGM2 | |
| SCHEMBL243791 | 0.72 | TSHR (0.38) | TSHRALDH1A1AKT1 | |
| SCHEMBL1066599 | 0.72 | TSHR (0.38) | TSHRALDH1A1AKT1ALOX15TGM2 | |
| SCHEMBL5049897 | 0.72 | TSHR (0.38) | TSHRALDH1A1AKT1 | |
| SCHEMBL16508016 | 0.72 | TSHR (0.38) | TSHRALDH1A1AKT1 | |
| SCHEMBL2270554 | 0.72 | ALDH1A1 (0.38) | TSHRALDH1A1AKT1 | |
| SCHEMBL7994863 | 0.72 | TSHR (0.38) | TSHRALDH1A1AKT1ALOX15TGM2 | |
| SCHEMBL10867723 | 0.72 | ALDH1A1 (0.38) | TSHRALDH1A1AKT1 | |
| SCHEMBL1493193 | 0.71 | ALDH1A1 (0.32) | TSHRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 120 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102597026-B | Process and catalyst system for polydiene production | BRIDGESTONE CORP | 2014-11-26 | — | — | CN | claimed |
| CN-102597026-A | Process and catalyst system for polydiene production | BRIDGESTONE CORP | 2012-07-18 | — | — | CN | claimed |
| US-7276567-B2 | Heterocyclic substituted metallocene compounds for olefin polymerization | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2007-10-02 | — | — | US | claimed |
| US-7151106-B2 | Crystal modification of a N-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use | NOVARTIS A.G. (CH) | 2006-12-19 | — | — | US | claimed |
| EP-1259556-B1 | IMPROVED DERIVATIVES OF SILANE FUNCTIONALIZED OLEFIN INTERPOLYMERS | DOW GLOBAL TECHNOLOGIES INC (US) | 2006-06-07 | — | — | EP | claimed |
| US-5516871-A | Diphenylsiloxane oligomers functionalized at both terminals and methods for the preparation thereof | DOW CORNING ASIA, LTD. (JP) | 1996-05-14 | — | — | US | claimed |
| US-5502229-A | ENDCAPPING | DOW CORNING ASIA, LTD. (JP) | 1996-03-26 | — | — | US | claimed |
| JP-7097410-A | — | — | None | — | — | JP | disclosed |
| US-12466850-B2 | Method for producing peptide compound | NISSAN CHEMICAL CORPORATION (JP) | 2025-11-11 | — | — | US | disclosed |
| US-12384861-B2 | Crosslinked compositions from olefin/silane interpolymers | DOW GLOBAL TECHNOLOGIES LLC (US) | 2025-08-12 | — | — | US | disclosed |
| CN-116171304-B | Cross-linking compositions from olefin/silane interpolymers | 陶氏环球技术有限责任公司 | 2025-05-23 | — | — | CN | disclosed |
| US-20250145795-A1 | OLEFIN/SILANE INTERPOLYMER COMPOSITIONS WITH EXCELLENT THERMAL OXIDATION RESISTANCE | DOW GLOBAL TECHNOLOGIES LLC (US) | 2025-05-08 | — | — | US | disclosed |
| US-20250136798-A1 | OLEFIN/SILANE INTERPOLYMER COMPOSITIONS WITH REDUCED RESIDUAL ALDEHYDE AND/OR KETONE CONTENT | DOW GLOBAL TECHNOLOGIES LLC (US) | 2025-05-01 | — | — | US | disclosed |
| US-4728709-A | Terminal cluster vinyl silicones and acrylate cluster silicones therefrom | LOCTITE CORPORATION (US) | 1988-03-01 | — | — | US | disclosed |
| EP-0186705-A1 | TERMINAL CLUSTER ACRYLATE SILICONES. | LOCTITE CORP (US) | 1986-07-09 | — | — | EP | disclosed |
| US-4575545-A | Terminal cluster acrylate silicones | LOCTITE CORPORATION (US) | 1986-03-11 | — | — | US | disclosed |
| US-4575546-A | Terminal cluster vinyl silicones and acrylate cluster silicones therefrom | LOCTITE CORPORATION (US) | 1986-03-11 | — | — | US | disclosed |
| WO-1986000322-A1 | TERMINAL CLUSTER ACRYLATE SILICONES | LOCTITE CORPORATION (US) | 1986-01-16 | — | — | WO | disclosed |
| US-4135045-A | PROCESS FOR POLYMERIZATION OF OLEFINS AND CATALYST COMPOSITION THEREFOR | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1979-01-16 | — | — | US | disclosed |
| US-4048415-A | TITANIUM-ALUMINUM COORDINATION CATALYSTS | MITSUI PETROCHEMICAL INDUSTRIES LTD. (JA) | 1977-09-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12466850-B2 | Method for producing peptide compound | VIP, NGLY1, NPR1 | TSHR 288/4885ALDH1A1 4771/4885AKT1 3464/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.